Vaccines, blood, antisera, toxins and cultures in   Democratic Republic of the Congo

Exports In 2022, Democratic Republic of the Congo exported $3.41k in Vaccines, blood, antisera, toxins and cultures, making it the 174th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 473rd most exported product in Democratic Republic of the Congo. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Democratic Republic of the Congo are: Belgium ($1.67k), France ($811), Gabon ($359), Spain ($223), and Thailand ($128).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Democratic Republic of the Congo between 2021 and 2022 were Belgium ($1.48k), Thailand ($128), and Switzerland ($35).

Imports In 2022, Democratic Republic of the Congo imported $154M in Vaccines, blood, antisera, toxins and cultures, becoming the 84th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 19th most imported product in Democratic Republic of the Congo. Democratic Republic of the Congo imports Vaccines, blood, antisera, toxins and cultures primarily from: Belgium ($72.7M), France ($31M), India ($22.7M), South Korea ($14M), and United States ($8.41M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Democratic Republic of the Congo between 2021 and 2022 were Belgium ($34.6M), France ($18.9M), and Indonesia ($1.88M).